Please provide your email address to receive an email when new articles are posted on . Patients with moderate to severe aortic stenosis appear to have outcomes just as poor as those with severe ...

Please provide your email address to receive an email when new articles are posted on . TAVR did not improve a composite of clinical endpoints in patients with moderate aortic stenosis and HFrEF.

WASHINGTON, DC—For patients who have heart failure with reduced ejection fraction (HFrEF) accompanied by moderate aortic stenosis (AS), there’s not much to gain by doing TAVI before the valve disease ...

The diagnosed severity of aortic stenosis strongly correlates with clinical outcomes, new Kaiser Permanente research shows. But the study also suggests that fine-tuning physician assessment of those ...

Background Previous studies have suggested an adverse role of epicardial adipose tissue (EAT) in aortic stenosis (AS), ...

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...

The implication, some say, is that when TAVI expanded to lower-risk patients in 2019, death rates rose—not so fast, say ...

(RTTNews) - HeartSciences (HSCS, HSCSW) announced that the FDA has granted Breakthrough Device designation for its Aortic Stenosis ECG algorithm. The algorithm would offer a AI-driven ECG solution ...

In this Healthwatch 16, Newswatch 16's Emily Kress spoke with an expert about aortic stenosis and a procedure to treat it, called the trans aortic valve replacement.

The MarketWatch News Department was not involved in the creation of this content. Results presented in oral session demonstrated that treatment with ataciguat reduced aortic valve calcium and improved ...

WASHINGTON, DC – OCTOBER 28, 2024 – Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ...